Farmers & Merchants Investments Inc. Sells 500 Shares of Solventum Co. (NYSE:SOLV)

Farmers & Merchants Investments Inc. decreased its stake in shares of Solventum Co. (NYSE:SOLV) by 14.0% during the 4th quarter, Holdings Channel reports. The firm owned 3,079 shares of the company’s stock after selling 500 shares during the period. Farmers & Merchants Investments Inc.’s holdings in Solventum were worth $203,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Worldquant Millennium Advisors LLC increased its stake in shares of Solventum by 373.6% during the 3rd quarter. Worldquant Millennium Advisors LLC now owns 47,665 shares of the company’s stock worth $3,323,000 after purchasing an additional 37,600 shares during the last quarter. Harbor Capital Advisors Inc. increased its holdings in shares of Solventum by 24.8% during the 4th quarter. Harbor Capital Advisors Inc. now owns 46,965 shares of the company’s stock worth $3,103,000 after acquiring an additional 9,333 shares during the last quarter. The Manufacturers Life Insurance Company increased its holdings in shares of Solventum by 37.4% in the third quarter. The Manufacturers Life Insurance Company now owns 117,853 shares of the company’s stock valued at $8,217,000 after purchasing an additional 32,051 shares during the last quarter. State Street Corp grew its stake in Solventum by 3.1% in the 3rd quarter. State Street Corp now owns 6,107,550 shares of the company’s stock valued at $425,818,000 after buying an additional 185,938 shares during the last quarter. Finally, Forsta AP Fonden bought a new position in shares of Solventum during the fourth quarter worth approximately $1,876,000.

Solventum Stock Down 1.8 %

Shares of SOLV opened at $73.43 on Friday. The company has a current ratio of 1.15, a quick ratio of 0.83 and a debt-to-equity ratio of 2.45. Solventum Co. has a 52 week low of $47.16 and a 52 week high of $96.05. The stock has a fifty day moving average of $70.40 and a 200-day moving average of $67.94.

Solventum (NYSE:SOLV) last posted its earnings results on Thursday, November 7th. The company reported $1.15 EPS for the quarter, missing the consensus estimate of $1.38 by ($0.23). The business had revenue of $2.08 billion during the quarter, compared to analysts’ expectations of $2.05 billion. As a group, research analysts forecast that Solventum Co. will post 6.58 EPS for the current fiscal year.

Wall Street Analyst Weigh In

SOLV has been the subject of several recent research reports. Mizuho assumed coverage on Solventum in a research report on Wednesday, December 4th. They set a “neutral” rating and a $70.00 price target on the stock. Morgan Stanley raised their price target on Solventum from $60.00 to $73.00 and gave the stock an “equal weight” rating in a research report on Monday, November 11th. Finally, Piper Sandler upped their price objective on shares of Solventum from $71.00 to $75.00 and gave the stock a “neutral” rating in a research report on Friday, November 8th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and one has given a buy rating to the company’s stock. According to MarketBeat, Solventum has a consensus rating of “Hold” and a consensus price target of $68.29.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.